![Implications of driver genes associated with a high tumor mutation burden identified using next‑generation sequencing on immunotherapy in hepatocellular carcinoma Implications of driver genes associated with a high tumor mutation burden identified using next‑generation sequencing on immunotherapy in hepatocellular carcinoma](https://www.spandidos-publications.com/article_images/ol/19/4/ol-19-04-2739-g03.jpg)
Implications of driver genes associated with a high tumor mutation burden identified using next‑generation sequencing on immunotherapy in hepatocellular carcinoma
![Omics analyses of a somatic Trp53R245W/+ breast cancer model identify cooperating driver events activating PI3K/AKT/mTOR signaling | PNAS Omics analyses of a somatic Trp53R245W/+ breast cancer model identify cooperating driver events activating PI3K/AKT/mTOR signaling | PNAS](https://www.pnas.org/cms/asset/23ba059c-dde0-4a65-bb59-f591aac3ba23/keyimage.jpg)
Omics analyses of a somatic Trp53R245W/+ breast cancer model identify cooperating driver events activating PI3K/AKT/mTOR signaling | PNAS
![Implications of driver genes associated with a high tumor mutation burden identified using next‑generation sequencing on immunotherapy in hepatocellular carcinoma Implications of driver genes associated with a high tumor mutation burden identified using next‑generation sequencing on immunotherapy in hepatocellular carcinoma](https://www.spandidos-publications.com/article_images/ol/19/4/ol-19-04-2739-g00.jpg)
Implications of driver genes associated with a high tumor mutation burden identified using next‑generation sequencing on immunotherapy in hepatocellular carcinoma
![Mutant p53 achieved Gain-of-Function by promoting tumor growth and immune escape through PHLPP2/AKT/PD-L1 pathway Mutant p53 achieved Gain-of-Function by promoting tumor growth and immune escape through PHLPP2/AKT/PD-L1 pathway](https://www.ijbs.com/v18/p2419/toc.jpg)
Mutant p53 achieved Gain-of-Function by promoting tumor growth and immune escape through PHLPP2/AKT/PD-L1 pathway
![Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden | Genome Medicine | Full Text Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden | Genome Medicine | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13073-017-0424-2/MediaObjects/13073_2017_424_Fig1_HTML.gif)
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden | Genome Medicine | Full Text
![Germline TP53 mutations undergo copy number gain years prior to tumor diagnosis | Nature Communications Germline TP53 mutations undergo copy number gain years prior to tumor diagnosis | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-022-35727-y/MediaObjects/41467_2022_35727_Fig1_HTML.png)
Germline TP53 mutations undergo copy number gain years prior to tumor diagnosis | Nature Communications
Recurrent somatic mutations reveal new insights into consequences of mutagenic processes in cancer | PLOS Computational Biology
![Frontiers | A TP53-Associated Immune Prognostic Signature for the Prediction of Overall Survival and Therapeutic Responses in Muscle-Invasive Bladder Cancer Frontiers | A TP53-Associated Immune Prognostic Signature for the Prediction of Overall Survival and Therapeutic Responses in Muscle-Invasive Bladder Cancer](https://www.frontiersin.org/files/Articles/590618/fimmu-11-590618-HTML-r1/image_m/fimmu-11-590618-g001.jpg)
Frontiers | A TP53-Associated Immune Prognostic Signature for the Prediction of Overall Survival and Therapeutic Responses in Muscle-Invasive Bladder Cancer
![Gaining insights into relevance across cancers based on mutation features of TP53 gene - ScienceDirect Gaining insights into relevance across cancers based on mutation features of TP53 gene - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2405580821002594-gr1.jpg)
Gaining insights into relevance across cancers based on mutation features of TP53 gene - ScienceDirect
![An unexpected role for p53 in regulating cancer cell–intrinsic PD-1 by acetylation | Science Advances An unexpected role for p53 in regulating cancer cell–intrinsic PD-1 by acetylation | Science Advances](https://www.science.org/cms/10.1126/sciadv.abf4148/asset/4ffd7084-9411-4a53-919a-99b55cd1d114/assets/graphic/abf4148-f1.jpeg)
An unexpected role for p53 in regulating cancer cell–intrinsic PD-1 by acetylation | Science Advances
Targeting Cavity-Creating p53 Cancer Mutations with Small-Molecule Stabilizers: the Y220X Paradigm | ACS Chemical Biology
![TP53 mutational landscape of metastatic head and neck cancer reveals patterns of mutation selection - eBioMedicine TP53 mutational landscape of metastatic head and neck cancer reveals patterns of mutation selection - eBioMedicine](https://www.thelancet.com/cms/attachment/74cf262e-7a71-4d6b-a767-a7a32f8fc154/gr2_lrg.jpg)
TP53 mutational landscape of metastatic head and neck cancer reveals patterns of mutation selection - eBioMedicine
![TP53 mutation spectrum in primary colorectal cancers. a Proportion of... | Download Scientific Diagram TP53 mutation spectrum in primary colorectal cancers. a Proportion of... | Download Scientific Diagram](https://www.researchgate.net/publication/333120263/figure/fig1/AS:759000865980418@1557971316867/TP53-mutation-spectrum-in-primary-colorectal-cancers-a-Proportion-of-TP53-mutation.png)
TP53 mutation spectrum in primary colorectal cancers. a Proportion of... | Download Scientific Diagram
![LRP1B or TP53 mutations are associated with higher tumor mutational burden and worse survival in hepatocellular carcinoma LRP1B or TP53 mutations are associated with higher tumor mutational burden and worse survival in hepatocellular carcinoma](https://www.jcancer.org/v12/p0217/jcav12p0217g002.jpg)
LRP1B or TP53 mutations are associated with higher tumor mutational burden and worse survival in hepatocellular carcinoma
![Cancers | Free Full-Text | TP53 Combined Phenotype Score Is Associated with the Clinical Outcome of TP53-Mutated Myelodysplastic Syndromes Cancers | Free Full-Text | TP53 Combined Phenotype Score Is Associated with the Clinical Outcome of TP53-Mutated Myelodysplastic Syndromes](https://www.mdpi.com/cancers/cancers-13-05502/article_deploy/html/images/cancers-13-05502-g001.png)